The Boston Naming Test identifies presymptomatic anomia in
            MAPT
            mutation carriers

AbstractMutations in the progranulin (PGRN) gene have been identified as a cause of frontotemporal dementia (FTD). However, little is known about the neuropsychological abilities of asymptomatic carriers of these mutations. The aim of the study was to assess cognitive functioning in asymptomatic c.709-1G>A PGRN mutation carriers. We hypothesized that poorer neuropsychological performance could be present before the development of clinically significant FTD symptoms. Thirty-two asymptomatic first-degree relatives of FTD patients carrying the c.709-1G>A mutation served as study participants, including 13 PGRN mutation carriers (A-PGRN+) and 19 non-carriers (PGRN-). A neuropsychological battery was administered. We found that the A-PGRN+ participants obtained significantly poorer scores than PGRN- individuals on tests of attention (Trail-Making Test Part A), mental flexibility (Trail-Making Test Part B), and language (Boston Naming Test). Poorer performance on these tests in asymptomatic PGRN mutation carriers may reflect a prodromal phase preceding the onset of clinically significant symptoms of FTD. (JINS, 2012, 18, 1086–1090)

Download Full-text

Relationship between semantic and serial learning strategy on the CVLT with components of the Boston Naming Test and the WAIS-III

PsycEXTRA Dataset ◽

10.1037/e536342014-001 ◽

2014 ◽

Author(s):

Supria K. Gill ◽

Emma M. Shapiro ◽

James A. Moses

Keyword(s):

Learning Strategy ◽

Serial Learning ◽

Boston Naming Test ◽

Naming Test

Download Full-text

Boston Naming Test--Turkish Version

PsycTESTS Dataset ◽

10.1037/t73641-000 ◽

2018 ◽

Author(s):

Ayten Ekinci Soylu ◽

Banu Cangöz

Keyword(s):

Turkish Version ◽

Boston Naming Test ◽

Naming Test

Download Full-text

Faculty Opinions recommendation of MRS in presymptomatic MAPT mutation carriers: a potential biomarker for tau-mediated pathology.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.6742956.6907054 ◽

2010 ◽

Author(s):

Martin Rossor ◽

Jonathan Rohrer

Keyword(s):

Mutation Carriers ◽

Potential Biomarker ◽

Mapt Mutation

Download Full-text

Psychometric Equivalence of Standard and Prorated Boston Naming Test Scores

Assessment ◽

10.1177/1073191120983925 ◽

2020 ◽

pp. 107319112098392

Author(s):

Danielle Zimmerman ◽

J. Attridge ◽

Summer Rolin ◽

Jeremy Davis

Keyword(s):

Race And Ethnicity ◽

Test Scores ◽

Concordance Correlation ◽

Physical Medicine ◽

Boston Naming Test ◽

Item Score ◽

Perfect Agreement ◽

Psychometric Equivalence ◽

Equivalence Tests ◽

Naming Test

This study compared prorated Boston Naming Test (BNT-P; omitting the noose item) and standard administration (BNT-S) scores in physical medicine and rehabilitation patients ( N = 480). The sample was 34% female and 91% White with average age and education of 46 ( SD = 15) and 14 ( SD = 3) years, respectively. BNT-P was calculated by summing correct responses excluding item 48 and estimating the 60-item score with cross multiplication and division. BNT-P and BNT-S scores were compared via concordance correlation (CC) coefficients; reflected and log transformed data were examined with equivalence tests. BNT-P and BNT-S scores showed almost perfect agreement (CC = .99). Transformed scores demonstrated equivalence (±1.1 points). Raw and scaled score differences were 0 in 88% and 96% of cases, respectively. Race and ethnicity accounted for item 48 outcomes while controlling for age and education. Findings support the utility of prorated BNT scores in rehabilitation patients.

Download Full-text